Matthew W. Emmens
2009
In 2009, Matthew W. Emmens earned a total compensation of $19.3M as Chair, President CEO at Vertex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $2,846,251 |
|---|---|
| Option Awards | $10,699,406 |
| Salary | $1,002,693 |
| Stock Awards | $4,498,687 |
| Other | $231,121 |
| Total | $19,278,158 |
Emmens received $10.7M in option awards, accounting for 56% of the total pay in 2009.
Emmens also received $2.8M in non-equity incentive plan, $1M in salary, $4.5M in stock awards and $231.1K in other compensation.
Rankings
In 2009, Matthew W. Emmens' compensation ranked 51st out of 9,885 executives tracked by ExecPay. In other words, Emmens earned more than 99.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 51 out of 9,885 | 100th |
Division Manufacturing | 16 out of 3,690 | 100th |
Major group Chemicals And Allied Products | 8 out of 871 | 99th |
Industry group Drugs | 8 out of 643 | 99th |
Industry Pharmaceutical Preparations | 8 out of 446 | 98th |
Source: SEC filing on April 10, 2012.
Emmens' colleagues
We found six more compensation records of executives who worked with Matthew W. Emmens at Vertex Pharmaceuticals in 2009.
2009
Nancy Wysenski
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2009
Joshua Boger
Vertex Pharmaceuticals
Chief Executive Officer
2009
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2009
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2009
Amit Sachdev
Vertex Pharmaceuticals
Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada
2009
Kenneth Boger
Vertex Pharmaceuticals